Profile data is unavailable for this security.
About the company
Shanghai MicuRx Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development (R&D) and commercialization of innovative drugs. The Company's antibacterial drug product, contezolid tablets, can be applied to treat infections caused by multidrug-resistant gram-positive bacteria. The Company also has a number of new anti-drug-resistant bacteria, kidney cancer, nephritis drugs and anti-new crown drug pipelines in the preclinical stage, including MRX-4, MRX-5, MRX-7, MRX-15, MRX-17 and others. The Company operates its businesses primarily in the domestic market.
- Revenue in CNY (TTM)106.52m
- Net income in CNY-467.10m
- Incorporated2012
- Employees205.00
- LocationShanghai MicuRx Pharmaceutical Co LtdSHANGHAI 201210ChinaCHN
- Phone+86 2 150900550
- Fax+86 2 161101898
- Websitehttp://www.micurxchina.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chemclin Diagnostics Co Ltd | 455.80m | 150.93m | 3.05bn | 731.00 | 20.19 | 2.20 | -- | 6.69 | 0.3764 | 0.3764 | 1.14 | 3.45 | 0.2684 | 1.02 | 17.03 | 623,526.50 | 8.89 | 11.01 | 9.82 | 12.32 | 74.73 | 74.19 | 33.11 | 31.07 | 5.09 | -- | 0.1518 | 36.64 | -4.28 | 4.00 | -3.44 | -- | 44.10 | -- |
| Shanghai MicuRx Pharmaceutical Co Ltd | 106.52m | -467.10m | 3.09bn | 205.00 | -- | 4.16 | -- | 28.97 | -0.7129 | -0.7129 | 0.1626 | 1.13 | 0.0839 | 0.5802 | 5.74 | 519,588.20 | -36.81 | -- | -40.09 | -- | 81.75 | -- | -438.53 | -- | 6.94 | -- | 0.2497 | -- | 88.31 | -- | -91.16 | -- | -- | -- |
| ChengDu Sheng Nuo Biotec Co Ltd | 457.56m | 72.78m | 3.09bn | 1.13k | 42.39 | 3.45 | -- | 6.76 | 0.651 | 0.651 | 4.09 | 8.00 | 0.3505 | 0.9497 | 4.57 | 405,639.80 | 5.57 | 7.47 | 7.00 | 9.44 | 62.46 | 70.52 | 15.90 | 15.82 | 1.28 | 16.72 | 0.2495 | 21.83 | 9.93 | 9.37 | 9.08 | 18.69 | 54.71 | -- |
| GuiZhou YiBai Pharmaceutical Co., Ltd. | 2.71bn | -9.06m | 3.10bn | 5.51k | -- | 1.04 | -- | 1.15 | -0.0114 | -0.0114 | 3.42 | 3.79 | 0.56 | 1.47 | 11.26 | 491,815.10 | -0.4457 | 0.8618 | -0.6067 | 1.17 | 66.49 | 74.87 | -0.7958 | 1.45 | 1.32 | 1.67 | 0.2392 | 216.36 | 3.12 | -6.19 | 124.25 | -- | -16.51 | -- |
| Hangzhou Biotest Biotech Co Ltd | 456.72m | -19.60m | 3.12bn | 730.00 | -- | 1.29 | -- | 6.83 | -0.1838 | -0.1838 | 4.28 | 22.68 | 0.1649 | 2.24 | 6.74 | 625,641.70 | -0.7862 | -- | -0.8521 | -- | 22.27 | -- | -4.77 | -- | 16.16 | -- | 0.0014 | -- | 4.57 | -- | -7.19 | -- | -- | -- |
| Bide Pharmatech Co Ltd | 1.10bn | 98.72m | 3.13bn | 846.00 | 31.64 | 1.53 | -- | 2.84 | 1.09 | 1.09 | 12.14 | 22.50 | 0.4585 | 1.09 | 4.76 | 1,302,686.00 | 4.06 | -- | 4.62 | -- | 38.38 | -- | 8.86 | -- | 5.29 | -- | 0.0416 | -- | 30.94 | -- | -24.94 | -- | -- | -- |
Data as of May 21 2024. Currency figures normalised to Shanghai MicuRx Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
6.17%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Zhong Ou Asset Management Co., Ltdas of 31 Dec 2023 | 16.21m | 4.69% |
| China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 1.79m | 0.52% |
| Gfund Management Co., Ltd.as of 31 Dec 2023 | 914.07k | 0.27% |
| ABC-CA Fund Management Co., Ltd.as of 31 Dec 2023 | 876.32k | 0.25% |
| Golden Trust Sinopac Fund Management Co., Ltd.as of 31 Dec 2023 | 687.00k | 0.20% |
| Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 204.83k | 0.06% |
| CPIC Fund Management Co. Ltd.as of 31 Dec 2023 | 174.23k | 0.05% |
| Penghua Fund Management Co., Ltd.as of 31 Dec 2023 | 166.73k | 0.05% |
| Western Leadbank Fund Management Co., Ltdas of 31 Dec 2023 | 150.10k | 0.04% |
| Bank of China Investment Management Co., Ltd.as of 31 Dec 2023 | 142.41k | 0.04% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
